Login / Signup

In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.

Luigi Angelo VairaGiacomo De RiuPaolo Boscolo-RizzoClaire HopkinsJérôme René Lechien
Published in: Journal of medical virology (2022)
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • sars cov
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • oxidative stress